Bioorganic and Medicinal Chemistry p. 5378 - 5391 (2014)
Update date:2022-08-29
Topics:
Reddy, Tummala R.K.
Li, Chan
Guo, Xiaoxia
Fischer, Peter M.
Dekker, Lodewijk V.
Recent target validation studies have shown that inhibition of the protein interaction between annexin A2 and the S100A10 protein may have potential therapeutic benefits in cancer. Virtual screening identified certain 3,4,5-trisubstituted 4H-1,2,4-triazoles as moderately potent inhibitors of this interaction. A series of analogues were synthesized based on the 1,2,4-triazole scaffold and were evaluated for inhibition of the annexin A2-S100A10 protein interaction in competitive binding assays. 2-[(5-{[(4,6-Dimethylpyrimidin-2-yl)sulfanyl]methyl}-4-(furan-2-ylmethyl)-4H-1,2,4-triazol-3-yl)sulfanyl]-N-[4-(propan-2-yl)phenyl]acetamide (36) showed improved potency and was shown to disrupt the native complex between annexin A2 and S100A10.
View MoreNanJing KaiHeng Chemical CO., LTD.
Contact:+86-25-85768391
Address:RM.1704, D, WANDA PLAZA, NO.110, MIDDLE JIANGDONG ROAD, NANJING, CHINA
NingBO Hong Xiang Biochem.Co.Ltd
website:http://www.hxbiochem.com
Contact:0574-66003444
Address:Ning Bo Bei Lun
Chengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110622/58110118
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Doi:10.1021/ja00826a051
(1974)Doi:10.1021/ic801639e
(2008)Doi:10.1016/j.jallcom.2015.06.217
(2015)Doi:10.1039/c0gc00258e
(2010)Doi:10.1021/jo051936z
(2006)Doi:10.1016/j.tetlet.2019.03.044
(2019)